According to a new report by InsightAce Analytic, the “Biotechnology Contract Manufacturing Market” was expected to be worth $16.28 Bn in 2023 and is poised to reach $31.05 Bn by 2031, at a significant CAGR of 8.68% from 2024 to 2031. Market Analysis:
The biotechnology contract manufacturing market encompasses a wide range of services, including cell line development, upstream and downstream processing, formulation, fill-finish, and packaging. The…
Read More…
Source: https://www.openpr.com/news/3666794/biotechnology-contract-manufacturing-market-driving